Laboratory Testing in Disseminated Intravascular Coagulation

 

 Buy Article Permissions and Reprints

ABSTRACT

The lack of improvement in the clinical prognosis of disseminated intravascular coagulation (DIC) poses searching questions on the value of current laboratory testing in this area. There is little immediate chance of advancement unless new tests or new modes of analyzing currently available tests place an emphasis on identifying the early phase of DIC. An equal emphasis is also required on practicality to ensure that recommendations are applicable to the routine clinical setting. These two priorities need to be fulfilled to facilitate earlier therapeutic intervention in the clinical trials required for formal assessment of promising and emerging new molecules from successful animal studies. This article therefore discusses the advantages and disadvantages of available assays in DIC with these perspectives in mind. It also proposes a format to bring together the necessary elements required to make an impact on ultimately delivering clinical improvement in this critical area.

REFERENCES

• 1 Spero J A, Lewis J H, Hasiba U. Disseminated intravascular coagulation: findings in 346 patients.  Thromb Haemost . 1980;  43 28-33
  PubMedGoogle Scholar
• 2 Astiz M E, Rackow E C. Septic shock.  Lancet . 1998;  351 1501-1505
  CrossrefPubMedGoogle Scholar
• 3 Siegal T, Seligsohn U, Aghai E, Modan M. Clinical and laboratory aspects of disseminated intravascular coagulation: A study of 118 cases.  Thromb Haemost . 1978;  39 122-134
  PubMedGoogle Scholar
• 4 Giles A R. Disseminated intravascular coagulation. In: Bloom A, Forbes C, Thomas D, Tuddenham E, eds. Haemostasis and Thrombosis New York: Churchill Livingstone 1994: 969-986
  Google Scholar
• 5 Olson J D, Kaufman H H, Moake J. The incidence and significance of hemostatic abnormalities in patients with head injuries.  Neurosurgery . 1989;  24 825-831
  CrossrefPubMedGoogle Scholar
• 6 Bick R L. Disseminated intravascular coagulation: Pathophysiological mechanisms and manifestations.  Semin Thromb Hemost . 1998;  24 3-18
  Article in Thieme ConnectPubMedGoogle Scholar
• 7 Colman R W, Robboy S J, Minna J D. Disseminated intravascular coagulation: An approach.  Am J Med . 1972;  52 679-689
  CrossrefPubMedGoogle Scholar
• 8 Raimondi P, Bongard O, de Moerloose P, Reber G, Waldvogel F. D-Dimer plasma concentration in various clinical conditions.  Thromb Res . 1993;  69 125-130
  CrossrefPubMedGoogle Scholar
• 9 Kobayashi N, Maekawa T, Takada M, Tanaka H, Gonmori H. Criteria for diagnosis of DIC based on analysis of clinical and laboratory findings in 345 DIC patients collected by the Research Committee on DIC in Japan.  Bibl Haematol . 1983;  49 265-275
  PubMedGoogle Scholar
• 10 Wada H, Wakita Y, Nakase T. Outcome of disseminated intravascular coagulation in relation to the score when treatment was begun.  Thromb Haemost . 1995;  74 848-852
  PubMedGoogle Scholar
• 11 Mesters R M, Mannucci P M, Coppola R. Factor VIIa and antithrombin III activity during severe sepsis and septic shock in neutropenic patients.  Blood . 1996;  88 881-886
  PubMedGoogle Scholar
• 12 Fijnvandraat K, Derkx B, Peters M. Coagulation activation and tissue necrosis in meningococcal septic shock: Severely reduced protein C levels predict a high mortality.  Thromb Haemost . 1995;  73 15-20
  PubMedGoogle Scholar
• 13 Gando S, Kameue T, Nanzaki S, Nakanishi Y. Disseminated intravascular coagulation is a frequent complication of systemic inflammatory response syndrome.  Thromb Haemost . 1996;  75 224-228
  PubMedGoogle Scholar
• 14 Wada H, Minamikawa K, Wakita Y. Hemostatic study before onset of disseminated intravascular coagulation.  Am J Hematol . 1993;  43 190-194
  CrossrefPubMedGoogle Scholar
• 15 Dempfle C E. The use of soluble fibrin in evaluating the acute and chronic hypercoaguable state.  Thromb Haemost . 1999;  82 673-683
  PubMedGoogle Scholar
• 16 Zuckerman L, Cohen E, Vager J P, Woodword E, Kaprini J A. Comparison of thromboelastography with common coagulation tests.  Thromb Haemost . 1981;  46 752-756
  PubMedGoogle Scholar
• 17 Mongan P D, Hosking M P. The role of desmopressin acetate in patients undergoing coronary artery bypass surgery. A controlled clinical trial with thromboelastographic risk stratification.  Anesthesiology . 1992;  77 38-46
  CrossrefPubMedGoogle Scholar
• 18 Downey C, Kazmi R, Toh C H. Novel and diagnostically applicable information from optical waveform analysis of blood coagulation in disseminated intravascular coagulation.  Br J Haematol . 1997;  98 68-73
  CrossrefPubMedGoogle Scholar
• 19 Toh C H, Downey C, Dwyre L. Thromboplastin sensitivity in waveform analysis.  Thromb Haemost . 2000;  84 517-518
  PubMedGoogle Scholar
• 20 Downey C, Kazmi R, Toh C H. Early identification and prognostic implications in disseminated intravascular coagulation through transmittance waveform analysis.  Thromb Haemost . 1998;  80 65-69
  PubMedGoogle Scholar
• 21 de Jonge E, Dekkers P E, Creasey A A. Tissue factor pathway inhibitor dose-dependently inhibits coagulation activation without influencing the fibrinolytic and cytokine response during human endotoxaemia.  Blood . 2000;  95 1124-1129
  PubMedGoogle Scholar
• 22 Minnema M C, Chang A CK, Jansen P M. Recombinant human antithrombin III improves survival and attenuates inflammatory responses in baboons lethally challenged with Escherichia coli Blood .  2000;  95 1117-1123
  PubMedGoogle Scholar
• 23 Wheeler A P, Bernard G R. Treating patients with severe sepsis.  N Engl J Med . 1999;  340 207-214
  CrossrefPubMedGoogle Scholar